We have previously proposed a ‘first-tier’ screening algorithm for SSc-PAH utilising serum N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and pulmonary function tests (PFTs) [14]. The gene discussed is NPPB; the disease is systemic sclerosis.